Author:
Freudenberg L.S.,Bockisch A.,Jentzen W.
Reference27 articles.
1. Frilling A, Gorges R, Tecklenborg K, Gassmann P, Bockhorn M, Clausen M, Broelsch CE (2000) Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 128:1067–1074
2. Alnafisi NS, Driedger AA, Coates G, Moote DJ, Raphael SJ (2000) FDG PET of recurrent or metastatic iodine-131-negative papillary thyroid carcinoma. J Nucl Med 41:1010–1015
3. Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY (1999) Value of FDG PET in papillary thyroid carcinoma with negative iodine-131 whole-body scan. J Nucl Med 40:986–992
4. Grunwald F, Kalicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, Schober O, Lerch H, Brandt-Mainz K, Burchert W, Hiltermann G, Cremerius U, Biersack HJ (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicenter study. Eur J Nucl Med 26:1547–1552
5. Hooft L, Hoekstra OS, Deville W, Lips P, Teule GJ, Boers M, van Tulder MW (2001) Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab 86:3779–3786
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献